Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,043
Closed -$1.04M 540
2023
Q2
$1.04M Buy
6,043
+3,936
+187% +$681K ﹤0.01% 463
2023
Q1
$351K Buy
+2,107
New +$345K ﹤0.01% 606
2022
Q4
Sell
-10,462
Closed -$1.55M 758
2022
Q3
$1.55M Buy
+10,462
New +$1.75M 0.01% 498
2022
Q1
Sell
-6,314
Closed -$1.54M 803
2021
Q4
$1.54M Buy
+6,314
New +$1.38M 0.01% 373
2021
Q2
Sell
-10,324
Closed -$1.63M 657
2021
Q1
$1.63M Buy
+10,324
New +$1.64M 0.01% 310
2020
Q3
Sell
-17,614
Closed -$2.41M 470
2020
Q2
$2.41M Buy
+17,614
New +$2.3M 0.01% 198

Other funds holding ZTS

Brookfield Corp's ZTS Position: Q3 2023 in Review

Brookfield Corp sold out of Zoetis (ZTS) in Q3 2023, closing a stake of 6,043 shares — an estimated $1.04M sold.

Brookfield Corp first reported a position in ZTS in Q2 2020 and held it in 6 quarters. The position peaked at $2.41M in Q2 2020. 1,628 funds tracked by Wall St. Rank hold ZTS as of Q3 2023.

  • Brookfield Corp reported no remaining Zoetis position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 6,043 Zoetis shares in Q3 2023, an estimated $1.04M.
  • Brookfield Corp first reported a position in Zoetis in Q2 2020 and held it in 6 quarters.
  • Brookfield Corp's Zoetis position peaked at $2.41M in Q2 2020.
  • 1,628 funds tracked by Wall St. Rank held Zoetis as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.